Muh-hwa C. Yang

No. 201, Sec. 2, Shipai Rd
Beitou, TPQ 11217, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 223 publications

Histopathology-inferred spatial transcriptomics characterizes the tumor microenvironment in 1,500 head and neck tumors and predicts clinical outcomes.

Histopathology-inferred spatial transcriptomics characterizes the tumor microenvironment in 1,500 head and neck tumors and predicts clinical outcomes.

Journal: bioRxiv : the preprint server for biology

Published: July 02, 2026

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.

Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 12, 2026

Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.

Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 10, 2026

Multi-agent chemotherapy for refractory head and neck cancer.

Multi-agent chemotherapy for refractory head and neck cancer.

Journal: Journal of the Chinese Medical Association : JCMA

Published: January 08, 2026

Platinum and 5-FU Salvage Therapy for Severe Liver Crisis in Metastatic Breast Cancer: Efficacy and Analysis of Prognostic Factors.

Platinum and 5-FU Salvage Therapy for Severe Liver Crisis in Metastatic Breast Cancer: Efficacy and Analysis of Prognostic Factors.

Journal: Cancer research and treatment

Published: November 18, 2025

Optimizing the timing of lymphocyte collection after stem cell harvesting in B-cell lymphoma and myeloma patients.

Optimizing the timing of lymphocyte collection after stem cell harvesting in B-cell lymphoma and myeloma patients.

Journal: Cytotherapy

Published: November 15, 2025

Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.

Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.

Journal: Oral oncology

Published: October 09, 2025

GSH as an A-A Type Allosteric Activator of PKM2: Modulating Cancer Cell Homeostasis and Ferroptosis Susceptibility.

GSH as an A-A Type Allosteric Activator of PKM2: Modulating Cancer Cell Homeostasis and Ferroptosis Susceptibility.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 02, 2025

Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.

Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.

Journal: Life sciences

Published: August 20, 2025

Research on the relations of intraventricular pressure gradients determined by echocardiography and left ventricular cardiotoxicity in the early stage of anthracycline chemotherapy

Research on the relations of intraventricular pressure gradients determined by echocardiography and left ventricular cardiotoxicity in the early stage of anthracycline chemotherapy

Journal: Zhonghua xin xue guan bing za zhi

Published: August 18, 2025

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology.

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2025

Showing 1-12 of 223

Last Updated: 09/26/2026